Strong US demand has pushed the skincare brand to seek NZD $4 million, as stock shortages and FDA registration open wider retail channels.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.